Works matching IS 15989100 AND DT 2024 AND VI 22 AND IP 2


Results: 9
    1

    Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies.

    Published in:
    Intestinal Research, 2024, v. 22, n. 2, p. 172, doi. 10.5217/ir.2023.00043
    By:
    • Kobayashi, Taku;
    • Matsuoka, Katsuyoshi;
    • Watanabe, Mamoru;
    • Hisamatsu, Tadakazu;
    • Hirai, Fumihito;
    • Milata, Joe;
    • Li, Xingyuan;
    • Morris, Nathan;
    • Arora, Vipin;
    • Ishizuka, Tomoko;
    • Matsuo, Koji;
    • Satoi, Yoichi;
    • Milch, Catherine;
    • Hibi, Toshifumi
    Publication type:
    Article
    2
    3
    4
    5

    A survey of current practices in post-polypectomy surveillance in Korea.

    Published in:
    Intestinal Research, 2024, v. 22, n. 2, p. 186, doi. 10.5217/ir.2023.00109
    By:
    • Kim, Jeongseok;
    • Gweon, Tae-Geun;
    • Kwak, Min Seob;
    • Kim, Su Young;
    • Kim, Seong Jung;
    • Kim, Hyun Gun;
    • Kim, Eun Ran;
    • Hong, Sung Noh;
    • Kim, Eun Sun;
    • Moon, Chang Mo;
    • Myung, Dae Seong;
    • Baek, Dong Hoon;
    • Oh, Shin Ju;
    • Lee, Hyun Jung;
    • Lee, Ji Young;
    • Jung, Yunho;
    • Chun, Jaeyoung;
    • Yang, Dong-Hoon
    Publication type:
    Article
    6
    7
    8
    9